Danielle S Wallace (Danielle Wallace)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Diffuse Large B Cell Lymphoma

Tyrosine Kinase

Chronic Lymphocytic Leukemia

Patient Reported Outcomes

Top Venues

Leukemia & lymphoma

Journal of cancer education : the official journal of the American Association for Cancer Education

This page only lists publications with an associated author ORCID identifier.

Publications

Danielle S Wallace, Paul M Barr
Ready, AIM, stop: ibrutinib plus venetoclax in MCL. Blood 144 (8) (2024)
Danielle S Wallace, Clive S Zent, Andrea M Baran, Patrick M Reagan, Carla Casulo, Geoffrey Rice, Jonathan W Friedberg, Paul M Barr
Acalabrutinib and High-Frequency Low-Dose Subcutaneous Rituximab for Initial Therapy of Chronic Lymphocytic Leukemia. Blood advances (2023)
Danielle S Wallace, Chris Rowland, Brian T Hill, Andrea M Baran, Carla Casulo, Patrick M Reagan, Allison M Winter, Reem Karmali, Jane N Winter, Leo I Gordon, Andrew Bui, Peter Sportelli, Hari P Miskin, Michael S Weiss, Jonathan W Friedberg, Shuo Ma, Paul M Barr
Phase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma. Leukemia & lymphoma (2023)
Brian T Hill, Shuo Ma, Clive S Zent, Andrea M Baran, Danielle S Wallace, Anjali S Advani, Allison M Winter, Jane N Winter, Leo I Gordon, Reem Karmali, Jane L Liesveld, Deborah A Mulford, Chris Rowland, Andrew Bui, Peter Sportelli, Hari P Miskin, Michael S Weiss, Jonathan W Friedberg, Paul M Barr
Response-Adapted, Time-Limited Venetoclax, Umbralisib and Ublituximab for Relapsed/Refractory Chronic Lymphocytic Leukemia. Blood advances (2023)
Danielle S Wallace, Denise Cochran, Jennifer Duff, Julia Close, Martina Murphy, Andrea Baran, Arpan Patel
A Multicentered Academic Medical Center Experience of a Simulated Root Cause Analysis (RCA) for Hematology/Oncology Fellows. Journal of cancer education : the official journal of the American Association for Cancer Education (2020)